The store will not work correctly when cookies are disabled.
1-(4-fluorobenzyl)-3-(5-nitrothiazol-2-yl)urea
ID: ALA4549247
PubChem CID: 91620345
Max Phase: Preclinical
Molecular Formula: C11H9FN4O3S
Molecular Weight: 296.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccc(F)cc1)Nc1ncc([N+](=O)[O-])s1
Standard InChI: InChI=1S/C11H9FN4O3S/c12-8-3-1-7(2-4-8)5-13-10(17)15-11-14-6-9(20-11)16(18)19/h1-4,6H,5H2,(H2,13,14,15,17)
Standard InChI Key: DJLQNFFDIGNMTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
6.8535 -6.6918 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.0730 -6.4369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0730 -5.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8535 -5.3651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3343 -6.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1552 -6.0285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5677 -5.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3886 -5.3181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7970 -4.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6178 -4.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0303 -3.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8512 -3.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2596 -4.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8512 -5.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0303 -5.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1552 -4.6078 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4097 -6.9218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6601 -6.5862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4959 -7.7382 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0768 -4.6088 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
4 3 1 0
5 4 2 0
6 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 10 1 0
11 12 2 0
13 12 1 0
14 13 2 0
15 14 1 0
10 15 2 0
7 16 2 0
1 5 1 0
2 17 1 0
17 18 2 0
17 19 1 0
13 20 1 0
M CHG 2 17 1 19 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.28 | Molecular Weight (Monoisotopic): 296.0379 | AlogP: 2.51 | #Rotatable Bonds: 4 |
Polar Surface Area: 97.16 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.52 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.19 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -2.67 |
References
1. (2017) Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy, |